About ChrysaLabs
ChrysaLabs is a company based in Montreal (Canada) founded in 2017 by Gabriel Mangeat, Jacques Michiels, Benjamin De Leener, and Samuel Fournier. ChrysaLabs has raised $11 million across 1 funding round from investors including Bayer, BDC and TELUS Ventures. ChrysaLabs offers products and services including ChrysaLabs Probe and ChrysaLabs App. ChrysaLabs operates in a competitive market with competitors including Trace Genomics, Stenon, Solum, FungiAlert and Krishitantra, among others.
- Headquarter Montreal, Canada
- Founders Gabriel Mangeat, Jacques Michiels, Benjamin De Leener, Samuel Fournier
-
Sectors
Agriculture
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Chrysalabs Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$11 M (USD)
in 1 rounds
-
Latest Funding Round
$11 M (USD), Series A
May 10, 2023
-
Investors
Bayer
& 7 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ChrysaLabs
ChrysaLabs offers a comprehensive portfolio of products and services, including ChrysaLabs Probe and ChrysaLabs App.
Device for 30-second AI-based soil chemical analysis and data collection.
App for viewing, exporting, and analyzing geo-referenced soil data in real-time.
People of ChrysaLabs
Unlock access to complete
Funding Insights of ChrysaLabs
ChrysaLabs has successfully raised a total of $11M through 1 strategic funding round. The most recent funding activity was a Series A round of $11 million completed in May 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in ChrysaLabs
ChrysaLabs has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include Bayer, BDC and TELUS Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments in multiple sectors are directed by TELUS Ventures.
|
Locked | Locked | Locked | |
|
Angel investment network supporting innovative entrepreneurs in Canada.
|
Locked | Locked | Locked | |
|
Early-stage AgTech startups are supported through investments.
|
Locked | Locked | Locked |
Investor details for ChrysaLabs
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ChrysaLabs
Investment portfolio details for ChrysaLabs
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ChrysaLabs
Detailed financials for ChrysaLabs
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Chrysalabs Comparisons
Peer comparison for ChrysaLabs
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ChrysaLabs
ChrysaLabs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Trace Genomics, Stenon, Solum, FungiAlert and Krishitantra, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of technologies to diagnose soil health and soil-borne disease prediction
|
|
| Locked | Locked | Locked |
Sensor-based soil analysis devices for nutrients and temperature are provided.
|
|
| Locked | Locked | Locked |
Precision farming hardware and software solutions are developed.
|
|
| Locked | Locked | Locked |
Provider of precision soil testing services and soil health management solutions for farmers
|
|
| Locked | Locked | Locked |
Platform developing tools for soil testing
|
Detailed competitors of ChrysaLabs
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Chrysalabs
Complete news archive for ChrysaLabs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ChrysaLabs
ChrysaLabs was founded in 2017 and raised its 1st funding round 6 years after it was founded.
ChrysaLabs is headquartered in Montreal, Canada. It is registered at Montreal, Quebec, Canada.
Samuel Fournier is the current CEO of ChrysaLabs. They have also founded this company.
ChrysaLabs is a funded company, having raised a total of $11M across 1 funding round to date.
ChrysaLabs was founded in 2017 in Montreal, Canada, and operates in the agritech sector. Technology solutions for real-time soil sampling are provided to producers and agronomists through a portable probe. Soil nutrients and health are measured using a patented spectroscopy interface combined with AI-based analysis. Operations focus on enabling on-site data collection to support agricultural decision-making.
ChrysaLabs's top competitors include Trace Genomics, FungiAlert and Stenon.
ChrysaLabs offers ChrysaLabs Probe and ChrysaLabs App.
ChrysaLabs has 8 investors. Key investors include Bayer, BDC, TELUS Ventures, Anges Québec, and Koan AgTech Fund.